Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Satellos BioscienceMSLE -1.96%37 3-Year Book Growth Rate is 36.80% as of Mar. 2026, which is 63% above its 10-year median of 22.55. GuruFocus rates MSLE with a GF Score™ of 37/100. The stock has 1 warning sign investors should review. Among 1,131 Biotechnology companies, Satellos Bioscience ranks better than 91.6% on this metric.
During the past 12 months, Satellos Bioscience's average Book Value per Share Growth Rate was -49.00% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 36.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 6 years, the highest 3-Year average Book Value per Share Growth Rate of Satellos Bioscience was 36.80% per year. The lowest was 8.30% per year. And the median was 22.55% per year.
Satellos Bioscience (NAS:MSLE) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Satellos Bioscience 3-Year Book Growth Rate Related Terms
MSLE vs VRTX, REGN, RVMD: 3-Year Book Growth Rate Comparison
For the Biotechnology subindustry, Satellos Bioscience's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Satellos Bioscience 3-Year Book Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Satellos Bioscience's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Satellos Bioscience's 3-Year Book Growth Rate falls into.
Satellos Bioscience 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 36.80% mean?
Satellos Bioscience (MSLE) has a 3-Year Book Growth Rate of 36.80% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Satellos Bioscience and its competitors. This is 63% above median its historical median of 22.55. Over the past decade, Satellos Bioscience's 3-Year Book Growth Rate has ranged from 8.30 to 36.80. According to the industry distribution chart, Satellos Bioscience ranks #95 out of 1131 companies in the Biotechnology industry, placing it in the top 8.4%.
Is Satellos Bioscience's 3-Year Book Growth Rate too high?
Satellos Bioscience's current 3-Year Book Growth Rate of 36.80% is 63% above median its 10-year median of 22.55. Over the past 10 years, this metric has ranged from a low of 8.30 to a high of 36.80. Based on the distribution chart, Satellos Bioscience ranks #95 out of 1131 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Satellos Bioscience has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Satellos Bioscience's 3-Year Book Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Satellos Bioscience ranks #95 out of 1131 companies for 3-Year Book Growth Rate. This places Satellos Bioscience in the top 8% of its industry — outperforming the majority of peers. Historically, Satellos Bioscience's own 3-Year Book Growth Rate has ranged from 8.30 to 36.80 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Biotechnology company?
A good 3-Year Book Growth Rate depends on the Biotechnology industry context. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Satellos Bioscience and its competitors. Satellos Bioscience's current 3-Year Book Growth Rate is 36.80%, which is 63% above median its own 10-year median of 22.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Satellos Bioscience stock overvalued right now?
Satellos Bioscience (MSLE) has a current 3-Year Book Growth Rate of 36.80%. The current 3-Year Book Growth Rate is 36.80%, which is 63% above median its 10-year median of 22.55. Satellos Bioscience's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Satellos Bioscience (MSLE), the current 3-Year Book Growth Rate is 36.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
37GF Score
Get the complete analysis for MSLE
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MSLE has been successfully added to your 
